Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories has informed the BSE that the trading window for dealing in its securities will remain closed from Wednesday, October 1, 2025, until two clear trading days after the announcement of unaudited financial results for the quarter ending September 30, 2025. This closure applies to all designated persons including promoters, directors, key managerial personnel, designated employees, and other connected persons, who have been advised not to trade during this period. The window closure is a routine insider trading compliance measure under the company's Code of Conduct for Prevention of Insider Trading. The date of the board meeting to approve the Q2 FY26 results will be communicated separately in due course.
This is a standard regulatory compliance filing and not a material event — it does not directly affect the stock price. However, it signals that the Q2 FY26 results announcement is approaching, which retail investors should monitor for potential earnings-related moves.